On Oct. 29, 2020, Emulate announced that it had entered into a Cooperative Research and Development Agreement (CRADA) with the FDA to enable multiple studies across FDA offices in priority research areas, including programs to evaluate COVID-19 vaccines and understand human immune response against SARS-CoV-2, the virus that causes COVID-19.